These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 17379046

  • 1. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
    Beaulieu AD, Peloso P, Bensen W, Clark AJ, Watson CP, Gardner-Nix J, Thomson G, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC.
    Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
    [Abstract] [Full Text] [Related]

  • 2. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
    Vorsanger G, Xiang J, Jordan D, Farrell J.
    Clin Ther; 2007 Jan; 29 Suppl():2520-35. PubMed ID: 18164919
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K.
    J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R, Wittels M, Molnar M, Kager I, Ziervogel G, Sittl R.
    Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R.
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [Abstract] [Full Text] [Related]

  • 7. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW.
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [Abstract] [Full Text] [Related]

  • 8. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH, Gould E.
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [Abstract] [Full Text] [Related]

  • 9. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 10. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 11. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
    Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N, Protocol TRP-CAN-1 Study Group.
    J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
    [Abstract] [Full Text] [Related]

  • 12. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 13. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 14. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 15. Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial.
    Thienthong S, Krisanaprakornkit W, Taesiri W, Thaninsurat N, Utsahapanich S, Klaichanad C.
    J Med Assoc Thai; 2004 Jan; 87(1):24-32. PubMed ID: 14971531
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of tramadol in treatment of chronic low back pain.
    Schnitzer TJ, Gray WL, Paster RZ, Kamin M.
    J Rheumatol; 2000 Mar; 27(3):772-8. PubMed ID: 10743823
    [Abstract] [Full Text] [Related]

  • 17. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M, Pekdemir M, Selekler HM.
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [Abstract] [Full Text] [Related]

  • 18. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
    Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, Darke AC.
    J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D.
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [Abstract] [Full Text] [Related]

  • 20. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.